PC
Paul Choi Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
42.9%
Neutral
28.6%
Negative
28.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sell
Maintained
| $50 |
34%
downside
| 1 | -23% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $100 |
35%
upside
| 1 | +17% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $55 |
36%
upside
| 1 | +2.9% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Sell
Downgraded
| $6 |
53%
downside
| 1 | -35% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $77 |
29%
upside
| 1 | -44% |
0
%
| 8 Oct ‘25 1 month ago |
|
|
|
Neutral
Initiated
| $20 |
14%
downside
| 1 | – |
–
| 25 Sep ‘25 2 months ago |
|
|
|
Buy
Initiated
| $47 |
7%
upside
| 1 | +12% |
0
%
| 17 Sep ‘25 2 months ago |
|